TP53 and neoplasm: Low-grade papillary noninvasive (LPN) tumours are frequently associated with deletions of chromosome 9 and defects of p16, a cyclin-dependent kinase inhibitor, but not with mutations of p53 tumour suppressor gene (Spruck et al, 1994; Orlow et al, 1995).